• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

降低结构性心脏病高危患者心脏性猝死风险的优化策略

Optimal Strategies for Mitigating Sudden Cardiac Death Risk in At-risk Patients with Structural Heart Disease.

作者信息

Boey Elaine, Kojodjojo Pipin

机构信息

Division of Cardiology, Ng Teng Fong General Hospital, National University Health System, Singapore.

出版信息

J Innov Card Rhythm Manag. 2018 Feb 15;9(2):3025-3032. doi: 10.19102/icrm.2018.090204. eCollection 2018 Feb.

DOI:10.19102/icrm.2018.090204
PMID:32494485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7252838/
Abstract

This article reviews the strategies used to mitigate sudden death risks in at-risk patients with structural heart disease. The roles of implantable and non-implantable technologies to prevent arrhythmic death are discussed.

摘要

本文回顾了用于降低有结构性心脏病的高危患者猝死风险的策略。讨论了可植入和不可植入技术在预防心律失常性死亡方面的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ac/7252838/91742ec2d373/icrm-09-3025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ac/7252838/91742ec2d373/icrm-09-3025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ac/7252838/91742ec2d373/icrm-09-3025-g001.jpg

相似文献

1
Optimal Strategies for Mitigating Sudden Cardiac Death Risk in At-risk Patients with Structural Heart Disease.降低结构性心脏病高危患者心脏性猝死风险的优化策略
J Innov Card Rhythm Manag. 2018 Feb 15;9(2):3025-3032. doi: 10.19102/icrm.2018.090204. eCollection 2018 Feb.
2
Genetic profiling as a marker for risk of sudden cardiac death.基因谱分析作为心脏性猝死风险的标志物
Curr Opin Cardiol. 2006 Jan;21(1):42-6. doi: 10.1097/01.hco.0000198982.86131.64.
3
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.肥厚型心肌病中的植入式心脏复律除颤器
Rev Port Cardiol. 2005 Mar;24(3):407-15.
4
[Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].[青年心脏性猝死。新型皮下植入式心律转复除颤器S-ICD是一种替代解决方案吗？]
Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):27-31. doi: 10.1016/j.ancard.2014.08.018. Epub 2014 Sep 18.
5
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.致心律失常性右室心肌病的风险分层
Circulation. 2017 Nov 21;136(21):2068-2082. doi: 10.1161/CIRCULATIONAHA.117.030792.
6
[The implantable cardioverter/defibrillator].[植入式心脏复律除颤器]
Herz. 1994 Oct;19(5):287-93.
7
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层：可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
8
Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada.加拿大植入式心脏复律除颤器与胺碘酮用于心源性猝死一级预防的成本效益分析。
Curr Med Res Opin. 2009 Mar;25(3):617-26. doi: 10.1185/03007990802695037.
9
Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.植入式心脏复律除颤器对晚期心力衰竭女性心脏性猝死一级预防的有效性：一项随机对照试验的荟萃分析。
Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.
10
[Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].[室性心律失常的药物和非药物治疗的长期结果]
J Cardiol. 2000 Mar;35 Suppl 1:75-84.

引用本文的文献

1
Implantable Cardioverter-defibrillator Use in Structural Heart Disease: Narrowing the Playing Field.植入式心脏复律除颤器在结构性心脏病中的应用：缩小范围
J Innov Card Rhythm Manag. 2018 Feb 15;9(2):3033-3034. doi: 10.19102/icrm.2018.090207. eCollection 2018 Feb.

本文引用的文献

1
Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator.一款无导线心脏再同步治疗除颤器和皮下植入式除颤器的即刻和 3 个月性能表现。
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1487-1498. doi: 10.1016/j.jacep.2017.04.002. Epub 2017 May 31.
2
Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials.非缺血性心肌病患者的一级预防植入式心脏复律除颤器：随机对照试验的荟萃分析
BMJ Open. 2017 Jun 21;7(6):e016352. doi: 10.1136/bmjopen-2017-016352.
3
Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator.
运动心电图在植入皮下植入式心脏除颤器后筛查 T 波过感知中的作用。
Heart Rhythm. 2017 Oct;14(10):1436-1439. doi: 10.1016/j.hrthm.2017.06.022. Epub 2017 Jun 15.
4
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.扩张型心肌病伴轻中度左心室收缩功能障碍患者中壁晚期钆增强与心源性猝死的关联
Circulation. 2017 May 30;135(22):2106-2115. doi: 10.1161/CIRCULATIONAHA.116.026910. Epub 2017 Mar 28.
5
Optimizing a Drone Network to Deliver Automated External Defibrillators.优化无人机网络以配送自动体外除颤器。
Circulation. 2017 Jun 20;135(25):2454-2465. doi: 10.1161/CIRCULATIONAHA.116.026318. Epub 2017 Mar 2.
6
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.非缺血性收缩性心力衰竭患者的除颤器植入
N Engl J Med. 2016 Sep 29;375(13):1221-30. doi: 10.1056/NEJMoa1608029. Epub 2016 Aug 27.
7
A before-after interventional trial of dispatcher-assisted cardio-pulmonary resuscitation for out-of-hospital cardiac arrests in Singapore.新加坡一项关于调度员辅助心肺复苏术用于院外心脏骤停的前后对照干预试验。
Resuscitation. 2016 May;102:85-93. doi: 10.1016/j.resuscitation.2016.02.014. Epub 2016 Mar 2.
8
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.《2016年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2016 Jan 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. Epub 2015 Dec 16.
9
Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience.新式心肌病患者佩戴式除颤器的实用性：长达十年的单中心经验。
J Am Coll Cardiol. 2015 Dec 15;66(23):2607-2613. doi: 10.1016/j.jacc.2015.09.079.
10
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).2015年欧洲心脏病学会（ESC）室性心律失常患者管理和心脏性猝死预防指南：欧洲心脏病学会（ESC）室性心律失常患者管理和心脏性猝死预防特别工作组。认可机构：欧洲儿科和先天性心脏病协会（AEPC）。
Eur Heart J. 2015 Nov 1;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316. Epub 2015 Aug 29.